KRS Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$432K Buy
1,700
+1
+0.1% +$233 0.2% 76
2026
Q1
$416K Buy
1,699
+15
+0.9% +$3.49K 0.25% 70
2025
Q4
$349K Sell
1,684
-26
-2% -$5.14K 0.2% 80
2025
Q3
$317K Sell
1,710
-145
-8% -$24.8K 0.19% 85
2025
Q2
$283K Sell
1,855
-181
-9% -$27.8K 0.19% 86
2025
Q1
$338K Sell
2,036
-566
-22% -$88.6K 0.27% 77
2024
Q4
$376K Sell
2,602
-97
-4% -$15K 0.27% 76
2024
Q3
$437K Sell
2,699
-296
-10% -$47.2K 0.32% 69
2024
Q2
$438K Sell
2,995
-135
-4% -$20.1K 0.33% 66
2024
Q1
$495K Sell
3,130
-480
-13% -$76.4K 0.4% 61
2023
Q4
$566K Sell
3,610
-190
-5% -$29.1K 0.53% 51
2023
Q3
$592K Sell
3,800
-92
-2% -$15.2K 0.63% 46
2023
Q2
$644K Buy
3,892
+106
+3% +$17.1K 0.64% 41
2023
Q1
$587K Buy
3,786
+36
+1% +$5.81K 0.66% 42
2022
Q4
$662K Buy
3,750
+41
+1% +$7.08K 0.91% 32
2022
Q3
$605K Buy
3,709
+7
+0.2% +$1.19K 0.83% 33
2022
Q2
$657K Buy
3,702
+41
+1% +$7.3K 0.94% 29
2022
Q1
$648K Buy
3,661
+6
+0.2% +$1.02K 0.7% 42
2021
Q4
$625K Buy
+3,655
New +$598K 0.54% 49

Other funds holding JNJ

KRS Capital Management's JNJ Position: Q2 2026 in Review

KRS Capital Management increased its Johnson & Johnson (JNJ) stake by 0.06% in Q2 2026, buying an estimated $233 and bringing the position to 1,700 shares worth $432K. The position accounts for 0.2% of the portfolio, ranked #76.

KRS Capital Management first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $662K in Q4 2022. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • KRS Capital Management held 1,700 shares of Johnson & Johnson worth $432K as of Q2 2026.
  • KRS Capital Management bought 1 Johnson & Johnson share in Q2 2026, an estimated $233.
  • Johnson & Johnson made up 0.2% of KRS Capital Management's portfolio in Q2 2026, its #76 holding.
  • KRS Capital Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • KRS Capital Management's Johnson & Johnson position peaked at $662K in Q4 2022.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on KRS Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.